The OxThera way

OxThera is aiming to change the life of patients suffering from hyperoxaluria. Our company is highly devoted to developing new drugs for patients with kidney disease, particularly in children. Read more

News from oxthera

OxThera is a biopharmaceutical company with products in late stage clinical development. The company develops biopharmaceuticals, based on its cell- and enzyme based proprietary technologies, for treatment of metabolic disorders causing hyperoxaluria. Read more

These are our products

OxThera develops biopharmaceuticals based on biologics and biomolecules. We have a long experience in the development of orally delivered biological drugs. Read more